IDEAYA Biosciences Inc. (IDYA)
23.44
0.70 (3.08%)
At close: Jan 15, 2025, 1:35 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -18.12 | -13.74 | -17.53 | -10.73 | -3.95 | -4.64 | -13.43 |
| PS Ratio | 87.52 | 14.79 | 29.83 | 17.71 | n/a | n/a | n/a |
| PB Ratio | 3.30 | 2.15 | 2.76 | 1.75 | 1.51 | -3.26 | -10.12 |
| P/FCF Ratio | -17.4 | -8.31 | -14.26 | 6.30 | -3.73 | -5.43 | -11.4 |
| P/OCF Ratio | -17.76 | -8.64 | -14.94 | 6.24 | -3.86 | -5.77 | -13.04 |
| OCF/S Ratio | -4.93 | -1.71 | -2 | 2.84 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.02 | 0.03 | 0.07 | n/a | -0.2 |
| Quick Ratio | 19.65 | 11.94 | 8.24 | 7.47 | 14.48 | 16.75 | 5.58 |
| Current Ratio | 19.65 | 11.68 | 5.56 | 7.47 | 14.48 | 16.75 | 5.58 |
| Asset Turnover | 0.04 | 0.13 | 0.07 | 0.07 | n/a | n/a | n/a |
| Interest Coverage | n/a | -16.25 | n/a | -41.63 | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.18 | -0.16 | -0.16 | -0.16 | -0.38 | 0.70 | 0.75 |
| Return on Assets (ROA) | -0.17 | -0.14 | -0.12 | -0.11 | -0.34 | -0.36 | -0.68 |
| Return on Capital (ROIC) | -0.22 | -0.18 | -0.15 | -0.14 | -0.42 | -0.4 | -0.96 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 82.86% | 95.87% | 93.83% | -103.18% | n/a | n/a | n/a |
| Net Profit Margin | -483.05% | -107.61% | -170.11% | -165.14% | n/a | n/a | n/a |
| Pretax Profit Margin | -483.05% | -115.17% | -178.1% | -176.55% | n/a | n/a | n/a |
| Operating Profit Margin | -574.85% | -122.72% | -179.91% | -180.9% | n/a | n/a | n/a |
| FCF Margin | -502.85% | -177.92% | -209.09% | 281.35% | n/a | n/a | n/a |
| EBITDA Margin | -557.71% | -118.59% | -173.73% | -173.83% | n/a | n/a | n/a |